Afatinib specifically inhibited EGFRvIII-cMET crosstalk in CSCs. »
06/18/19

Novel glyco-biomarkers with marked overexpression and distinguishing ability at early stage patients. »
06/17/19

Ectopic expression of Nanos3 in lungs has significant negative effect on survival. »
06/17/19

Proof-of-concept studies support use of integrative functional approach to personalized combination therapy. »
06/17/19

FN inhibitor induced chemoresistance via downregulation of ERK1/2 phosphorylation. »
06/17/19

14.3% of patients who received ≥ 10 mg of prednisone at immunotherapy initiation had shorter median progression-free survival. »
06/18/19

Interaction between menopausal status and BMI significant. »
01/25/19

EF outcomes after RP have not improved over last decade. »
06/26/18

A 20 nmol/L decrease in 25(OH) D not associated with melanoma risk. »
06/21/19

General structure of chemokines and their receptors as well as their potential significance in TC. »
04/24/19